BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 11920677)

  • 1. Regulation of cell proliferation by Smad proteins.
    Ten Dijke P; Goumans MJ; Itoh F; Itoh S
    J Cell Physiol; 2002 Apr; 191(1):1-16. PubMed ID: 11920677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crossing Smads.
    Wrana JL
    Sci STKE; 2000 Mar; 2000(23):re1. PubMed ID: 11752591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta signal transduction.
    Dennler S; Goumans MJ; ten Dijke P
    J Leukoc Biol; 2002 May; 71(5):731-40. PubMed ID: 11994497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.
    Javelaud D; Mauviel A
    Oncogene; 2005 Aug; 24(37):5742-50. PubMed ID: 16123807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent regulation of growth and SMAD-mediated transcription by transforming growth factor beta in human melanoma cells.
    Rodeck U; Nishiyama T; Mauviel A
    Cancer Res; 1999 Feb; 59(3):547-50. PubMed ID: 9973198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of transforming growth factor-beta signaling.
    Zhu HJ; Burgess AW
    Mol Cell Biol Res Commun; 2001 Nov; 4(6):321-30. PubMed ID: 11703090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles.
    Javelaud D; Mauviel A
    Int J Biochem Cell Biol; 2004 Jul; 36(7):1161-5. PubMed ID: 15109563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of Smads 1-6 in the 15-day gestation mouse embryo: signaling by BMPs and TGF-betas.
    Flanders KC; Kim ES; Roberts AB
    Dev Dyn; 2001 Feb; 220(2):141-54. PubMed ID: 11169847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of the TGF-beta-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-beta-induced growth arrest.
    Nicolás FJ; Hill CS
    Oncogene; 2003 Jun; 22(24):3698-711. PubMed ID: 12802277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transforming growth factor-betas: smad signaling and roles in physiopathology].
    Javelaud D; Mauviel A
    Pathol Biol (Paris); 2004 Feb; 52(1):50-4. PubMed ID: 14761714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
    Deacu E; Mori Y; Sato F; Yin J; Olaru A; Sterian A; Xu Y; Wang S; Schulmann K; Berki A; Kan T; Abraham JM; Meltzer SJ
    Cancer Res; 2004 Nov; 64(21):7690-6. PubMed ID: 15520171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta family signal transduction in Drosophila development: from Mad to Smads.
    Raftery LA; Sutherland DJ
    Dev Biol; 1999 Jun; 210(2):251-68. PubMed ID: 10357889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism.
    Schiller M; Verrecchia F; Mauviel A
    Oncogene; 2003 Dec; 22(55):8881-90. PubMed ID: 14654784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
    Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
    Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of current progress in the structure and function of Smad proteins.
    Chen W; Fu X; Sheng Z
    Chin Med J (Engl); 2002 Mar; 115(3):446-50. PubMed ID: 11940386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
    Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
    Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice.
    Oe S; Lemmer ER; Conner EA; Factor VM; Levéen P; Larsson J; Karlsson S; Thorgeirsson SS
    Hepatology; 2004 Nov; 40(5):1098-105. PubMed ID: 15389868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMAD pathway mediation of BDNF and TGF beta 2 regulation of proliferation and differentiation of hippocampal granule neurons.
    Lu J; Wu Y; Sousa N; Almeida OF
    Development; 2005 Jul; 132(14):3231-42. PubMed ID: 15958511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells.
    Noda D; Itoh S; Watanabe Y; Inamitsu M; Dennler S; Itoh F; Koike S; Danielpour D; ten Dijke P; Kato M
    Oncogene; 2006 Sep; 25(41):5591-600. PubMed ID: 16636667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.